Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorAntigens, CD34LeukapheresisHematologic NeoplasmsCombined Modality TherapyBlood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseMyeloablative AgonistsBusulfanGraft SurvivalTreatment OutcomeBone Marrow TransplantationLymphoma, Non-HodgkinHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineCord Blood Stem Cell TransplantationIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisStem CellsCytarabineDisease-Free SurvivalHodgkin DiseaseTransplantation ChimeraTissue DonorsRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationSurvival AnalysisTime FactorsHistocompatibility TestingHistocompatibilityInfectionLymphoma, T-CellBlood Cell CountPlatelet CountDoxorubicinPOEMS SyndromeTransplantation, IsogeneicBlood CellsPrednisoneCarboplatinLeukemia, Myeloid, AcuteImmunosuppressive AgentsLeukemiaDexamethasoneVidarabineFollow-Up StudiesRecombinant ProteinsAntineoplastic AgentsBone Marrow PurgingProspective StudiesLymphomaCytomegalovirus InfectionsGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesMyelodysplastic SyndromesImmunophenotypingLymphocyte DepletionAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesBlood Transfusion, AutologousLiver TransplantationT-LymphocytesHLA AntigensBlood DonorsLeukocytes, MononuclearHistiocytosis, Non-Langerhans-CellLivedo ReticularisOpportunistic InfectionsBone MarrowPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporinePrognosisLeukocyte CountBreast NeoplasmsFlow CytometryImmunosuppression